Innovative Medicines Canada (IMC) is pleased to contribute to the Quebec government’s consultations on its 2026-27 budget. Availability of and timely access to innovative medicines, like cancer therapies and vaccines, remains a significant issue for the province, with Quebec still lagging well behind other jurisdictions.
